Home LiteratureArticle Details
PMID: 2212939 Published · ppublish English Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Reinfection results in accumulation of unintegrated viral DNA in cytopathic and persistent human immunodeficiency virus type 1 infection of CEM cells.

The Journal of experimental medicine ·Vol. 172 ·No. 4 ·1990-10-01 ·Pages 1035-42

Pauza CD, Galindo JE, Richman DD

Abstract

High levels of unintegrated viral DNA accumulate during human immunodeficiency virus type 1 (HIV-1) infection of CEM T cells. Reinfection of already infected cells is required to attain these levels and reinfection also promotes the development of HIV-induced cytopathology. Rates of virus production, however, are independent of the accumulation of unintegrated viral DNA. Neutralizing antibody added soon after infection reduced viral DNA levels without appreciably affecting the production of cell-free viral p24 antigen or reverse transcriptase activity. Only 50 pM AZT were required to reduce the accumulation of unintegrated viral DNA by 50% in contrast to the 25 nM required to inhibit virus production by 50%. Cytopathology, as measured by number of syncytia in infected cell cultures, was correlated with highly elevated levels of unintegrated viral DNA. The minimal levels of unintegrated viral DNA present constitutively in the persistently infected HCEM cell line were consonant with the absence of cytopathic effects in these cells. These data demonstrate that inhibiting the reinfection of already infected cells modulates cytopathic HIV-1 infection to a form that is persistent and noncytopathic.

MeSH Terms
Antibodies, Monoclonal/immunology Cell Line DNA, Viral/metabolism Dose-Response Relationship, Drug HIV Long Terminal Repeat HIV-1/genetics,physiology Humans T-Lymphocytes/microbiology Zidovudine/pharmacology
Chemicals
Antibodies, Monoclonal DNA, Viral Zidovudine
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Pauza C D
Developmental Biology Laboratory, The Salk Institute for Biological Studies, San Diego, California 92138.
Galindo J E
Richman D D
References (33)
33 references, click to expand
  1. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.
    Science. 1984 May 4;224(4648):497-500 PMID: 6200935
  2. Selective extraction of polyoma DNA from infected mouse cell cultures.
    J Mol Biol. 1967 Jun 14;26(2):365-9 PMID: 4291934
  3. Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS.
    Science. 1984 Aug 24;225(4664):840-2 PMID: 6206563
  4. Molecular cloning of lymphadenopathy-associated virus.
    Nature. 1984 Dec 20-1985 Jan 2;312(5996):757-60 PMID: 6096717
  5. Molecular cloning of AIDS-associated retrovirus.
    Nature. 1984 Dec 20-1985 Jan 2;312(5996):760-3 PMID: 6096718
  6. Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen.
    J Immunol. 1985 Nov;135(5):3151-62 PMID: 2995487
  7. 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.
    Proc Natl Acad Sci U S A. 1985 Oct;82(20):7096-100 PMID: 2413459
  8. Disease-specific and tissue-specific production of unintegrated feline leukaemia virus variant DNA in feline AIDS.
    Nature. 1986 Jan 23-29;319(6051):333-6 PMID: 3001539
  9. Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex.
    Lancet. 1986 Mar 15;1(8481):575-80 PMID: 2869302
  10. AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen.
    Science. 1986 May 30;232(4754):1123-7 PMID: 3010463
  11. Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus.
    J Exp Med. 1986 Jul 1;164(1):280-90 PMID: 3014036
  12. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.
    Nature. 1986 Jul 31-Aug 6;322(6078):470-4 PMID: 3016552
  13. Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein.
    Nature. 1986 Oct 23-29;323(6090):725-8 PMID: 3095663
  14. Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV.
    Science. 1986 Nov 28;234(4780):1123-7 PMID: 3095925
  15. Clinical, immunologic, and serologic findings in men at risk for acquired immunodeficiency syndrome. The San Francisco Men's Health Study.
    JAMA. 1987 Jan 16;257(3):326-30 PMID: 3491910
  16. Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus.
    JAMA. 1987 Jan 16;257(3):331-4 PMID: 3491911
  17. Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitro.
    Antimicrob Agents Chemother. 1986 Dec;30(6):933-7 PMID: 2434024
  18. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.
    N Engl J Med. 1987 Jul 23;317(4):185-91 PMID: 3299089
  19. Failure of dideoxynucleosides to inhibit human immunodeficiency virus replication in cultured human macrophages.
    J Exp Med. 1987 Oct 1;166(4):1144-9 PMID: 2821152
  20. Dissociation of NS5 from cell fractions containing West Nile virus-specific polymerase activity.
    J Virol. 1987 Nov;61(11):3641-4 PMID: 2959795
  21. Resumption of virus production after human immunodeficiency virus infection of T lymphocytes in the presence of azidothymidine.
    J Virol. 1987 Dec;61(12):3769-73 PMID: 2446006
  22. Envelope glycoprotein of HIV induces interference and cytolysis resistance in CD4+ cells: mechanism for persistence in AIDS.
    Cell. 1988 May 6;53(3):483-96 PMID: 2966682
  23. Human immunodeficiency virus infection of monoblastoid cells: cellular differentiation determines the pattern of virus replication.
    J Virol. 1988 Oct;62(10):3558-64 PMID: 2458483
  24. Effects of anti-gp120 monoclonal antibodies on CD4 receptor binding by the env protein of human immunodeficiency virus type 1.
    J Virol. 1988 Oct;62(10):3695-702 PMID: 2458487
  25. Loss of CD4 membrane expression and CD4 mRNA during acute human immunodeficiency virus replication.
    J Exp Med. 1988 Dec 1;168(6):1953-69 PMID: 3264318
  26. HIV-1 infection abolishes CD4 biosynthesis but not CD4 mRNA.
    J Acquir Immune Defic Syndr. 1988;1(2):131-7 PMID: 3265152
  27. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy.
    Science. 1989 Mar 31;243(4899):1731-4 PMID: 2467383
  28. Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines.
    Science. 1989 May 5;244(4904):575-7 PMID: 2470148
  29. Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression.
    J Virol. 1989 Sep;63(9):3708-13 PMID: 2760980
  30. Viral DNA in horses infected with equine infectious anemia virus.
    J Virol. 1989 Dec;63(12):5194-200 PMID: 2555550
  31. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons.
    N Engl J Med. 1989 Dec 14;321(24):1621-5 PMID: 2586564
  32. Plasma viremia in human immunodeficiency virus infection.
    N Engl J Med. 1989 Dec 14;321(24):1626-31 PMID: 2511447
  33. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.
    Science. 1984 May 4;224(4648):500-3 PMID: 6200936
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1990-10-01
Pages
1035-42
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2188596
Subset
IM
Grants
NIAID NIH HHS · AI-24591 · United States
NIAID NIH HHS · AI-52578 · United States
NIAID NIH HHS · AI-62548 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]